Revenue and User Metrics - Total annual recurring revenue (Total ARR) as of September 30, 2025, was $2,536 million, a decrease from $2,574 million as of December 31, 2024, and $2,579 million as of September 30, 2024[219]. - The number of paying users as of September 30, 2025, was 18.07 million, down from 18.22 million as of December 31, 2024, and 18.24 million as of September 30, 2024[225]. - Average revenue per paying user (ARPU) for the three months ended September 30, 2025, was $139.07, slightly up from $139.05 for the same period in 2024[229]. - Revenue for the three months ended September 30, 2025, was $634.4 million, a slight decrease from $638.8 million in the same period of 2024; revenue for the nine months ended September 30, 2025, was $1,884.8 million, down from $1,904.6 million in 2024[253]. - Revenue for the nine months ended September 30, 2025, was $1,884.8 million, a decrease of $19.8 million or 1.0% compared to $1,904.6 million in 2024[264]. Financial Performance - The overall performance exceeded expectations amid ongoing macroeconomic uncertainty, with DocSend delivering strong growth while Dropbox Sign and FormSwift modestly exceeded expectations[211]. - Free cash flow (FCF) for the nine months ended September 30, 2025, was $705.9 million, an increase from $661.1 million in the same period of 2024, primarily due to higher cash from operating activities and lower capital expenditures[234]. - The net income for the three months ended September 30, 2025, was $123.8 million, an increase from $106.7 million in 2024; for the nine months, net income rose to $399.7 million from $349.5 million[253]. - The company expects free cash flow to generally increase in the near term due to operating efficiencies, despite anticipated increases in capital expenditures in the last quarter of 2025[233]. Expenses and Cost Management - The cost of revenue for the three months ended September 30, 2025, was $128.3 million, compared to $111.5 million in 2024; for the nine months, it increased to $368.7 million from $324.3 million[253]. - Gross profit for the three months ended September 30, 2025, was $506.1 million, down from $527.3 million in 2024; for the nine months, gross profit was $1,516.1 million, compared to $1,580.3 million in 2024[253]. - Operating expenses for the three months ended September 30, 2025, totaled $331.4 million, a decrease from $399.5 million in 2024; for the nine months, operating expenses were $989.2 million, down from $1,182.0 million[253]. - Research and development expenses for the three months ended September 30, 2025, were $182.3 million, compared to $225.7 million in 2024; for the nine months, these expenses decreased to $545.1 million from $671.9 million[253]. - Sales and marketing expenses for the three months ended September 30, 2025, were $91.5 million, down from $110.5 million in 2024; for the nine months, these expenses decreased to $271.3 million from $331.8 million[253]. - General and administrative expenses for the three months ended September 30, 2025, were $57.6 million, compared to $63.3 million in 2024; for the nine months, these expenses decreased to $170.2 million from $178.3 million[253]. Strategic Decisions and Investments - A strategic decision to significantly reduce investments in FormSwift at the beginning of 2025 negatively impacted annual recurring revenue (ARR), revenue, and paying users[202]. - The company incurred $3.7 million in expenses related to workforce reduction during the three and nine months ended September 30, 2025[213]. - The company primarily generates over 90% of its revenue from self-serve channels, encouraging registered users to convert to paid plans through various marketing tactics[208]. - The company’s business model includes a range of subscription plans tailored for individuals, families, teams, and organizations, with a focus on increasing conversion rates and expanding existing customers[200]. Macroeconomic Factors - Macroeconomic factors such as inflation and geopolitical issues may adversely impact the company's results of operations and financial performance[210]. Cash Flow and Financing Activities - For the nine months ended September 30, 2025, net cash provided by operating activities was $716.4 million, an increase of $36.1 million compared to the same period in 2024, primarily due to a $65.7 million increase in net income[284][287]. - Net cash used in financing activities for the nine months ended September 30, 2025, was $1,389.9 million, which included $1,298.9 million for the repurchase of common stock[293][294]. - The company completed three separate $1.2 billion Class A common stock repurchase programs since February 2022, with a new authorization for an additional $1.5 billion in August 2025[282]. - The company had $1,142.1 million outstanding under the term loan facility as of September 30, 2025, with $1,550.0 million available to draw[279][299]. - The company entered into a secured five-year term loan facility in December 2024 for up to $2.0 billion, with additional secured delayed draw term loan commitments of up to $700.0 million added in September 2025[278]. Foreign Currency Risks - 27% of the company's sales were denominated in currencies other than U.S. dollars during the nine months ended September 30, 2025[302]. - The company's expenses are primarily denominated in U.S. dollars, leading to potential margin declines if the U.S. dollar strengthens against foreign currencies[302]. - Foreign currency transaction gains or losses were immaterial for the nine months ended September 30, 2025 and 2024[303]. - A hypothetical 10% change in foreign currency rates would not have resulted in material gains or losses for the nine months ended September 30, 2025 and 2024[303]. - The company has not engaged in any hedging activities to manage foreign currency risks to date[303]. - The company's international operations are subject to fluctuations in foreign currency exchange rates, particularly the U.S. dollar-Euro and U.S. dollar-British pounds sterling exchange rates[302]. - The company will continue to reassess its approach to managing risks related to currency rate fluctuations as its international operations grow[303]. - Most of the company's revenue is generated in U.S. dollars, with the remainder in Euros, British pounds sterling, Australian dollars, Canadian dollars, and Japanese yen[300]. - The functional currency of the company's international headquarters is denominated in U.S. dollars[301]. - The company's results of operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates unrelated to operating performance[301].

Financial Performance - Net revenue for the three months ended September 30, 2025, increased to $26,067,000, up 22.5% from $21,309,000 for the same period in 2024[13] - Gross profit for the nine months ended September 30, 2025, was $49,495,000, a 32.4% increase compared to $37,355,000 for the same period in 2024[13] - The company reported a net income of $779,000 for the three months ended September 30, 2025, compared to a net loss of $9,124,000 for the same period in 2024[13] - For the nine months ended September 30, 2025, OptimizeRx Corporation reported a net income of $112, compared to a net loss of $20,032 for the same period in 2024[18] - Net revenue increased by 22% to $26,067 for the three months ended September 30, 2025, and by 29% to $77,190 for the nine months ended September 30, 2025, driven by DTC and DAAP related sales[120] Assets and Liabilities - Total assets as of September 30, 2025, decreased to $170,321,000 from $171,168,000 as of December 31, 2024, representing a decline of approximately 0.5%[11] - Cash and cash equivalents increased to $19,519,000 as of September 30, 2025, from $13,380,000 as of December 31, 2024, reflecting a growth of 46.0%[11] - The current portion of long-term debt rose to $3,300,000 as of September 30, 2025, compared to $2,000,000 as of December 31, 2024, indicating a 65.0% increase[11] - Long-term debt, net, decreased to $24,801 as of September 30, 2025, from $30,816 as of December 31, 2024[39] - The company had total current assets of approximately $56,320, resulting in working capital of approximately $37,854 and a current ratio of approximately 3.0 to 1[134] Equity and Stock - Total stockholders' equity increased to $122,263,000 as of September 30, 2025, from $116,998,000 as of December 31, 2024, marking a growth of 4.0%[11] - The weighted average number of shares outstanding for basic earnings per share increased to 18,576,199 for the three months ended September 30, 2025, compared to 18,323,542 for the same period in 2024[13] - The company had 166,666,667 shares of common stock authorized as of September 30, 2025, with 18,592,442 shares outstanding[54] - During the quarter ended September 30, 2025, the company issued 22,028 shares of common stock, receiving proceeds of $338[55] - The total intrinsic value of outstanding stock options at September 30, 2025, was $18,519[62] Expenses and Costs - Operating expenses for the three months ended September 30, 2025, were $15,466,000, down 29.9% from $22,009,000 in the same period of 2024[13] - Stock-based compensation for the nine months ended September 30, 2025, was $5,002, down from $8,530 in 2024[18] - Total lease cost for the nine months ended September 30, 2025, was $182, slightly down from $188 in the same period of 2024[52] - Cost of revenues as a percentage of revenue decreased to approximately 33% for the three months ended September 30, 2025, from approximately 37% in 2024[121] - Operating expenses decreased by approximately 30% to $15,466 for the three months ended September 30, 2025, and by approximately 15% to $46,371 for the nine months ended September 30, 2025[124] Cash Flow - The company experienced a net cash provided by operating activities of $11,627 for the nine months ended September 30, 2025, an increase from $4,691 in 2024[18] - The net increase in cash from operating activities was primarily due to a $20,144 increase in net income, partially offset by a $3,528 decrease in noncash expenses related to stock-based compensation[137] - Investing activities used $138 in cash during the nine months ended September 30, 2025, a decrease from $330 in the same period in 2024, mainly due to reduced capitalization of internally developed software[138] - Financing activities used $5,350 in cash during the nine months ended September 30, 2025, compared to $2,087 in the same period in 2024, primarily due to increased repayments of long-term debt[139] Revenue Recognition - Revenue recognized over time for the nine months ended September 30, 2025, was $77,017, up from $54,189 in 2024, indicating a growth of about 42.1%[79] - The company recognized $250 and $735 in revenue from contracts with Eversana for the three and nine months ended September 30, 2025, respectively, compared to $200 and $272 in 2024[84] - Deferred revenue as of September 30, 2025, was $395, down from $473 at December 31, 2024[77] - The allowance for credit losses at September 30, 2025, was $260, compared to $339 at the same date in 2024, showing a reduction of approximately 23.2%[81] Customer and Market Insights - The top five customers represented approximately 49% of the company's revenue for the year ended December 31, 2024[109] - The company is transitioning its Dynamic Audience Activation Platform (DAAP) customers to a subscription-based model, which is expected to improve margins and revenue predictability[108] - The percentage of total revenue attributable to top 20 pharmaceutical manufacturers decreased to 56% in 2025 from 65% in 2024, indicating growth from other customers[115] - Net revenue retention was 120% for the twelve months ended September 30, 2025, down from 127% in 2024, reflecting strong organic growth despite the lack of inorganic benefits from acquisitions[116] - Average revenue per top 20 pharmaceutical manufacturer increased to $3,073 for the twelve months ended September 30, 2025, compared to $2,874 for the same period in 2024[114] Debt and Financing - The company entered into a Financing Agreement on October 11, 2023, providing a term loan of $40 million, partially financing the Medicx Health transaction[39] - The term loan bears interest at 12.9%, with an effective interest rate of 15.9% for the three months ended September 30, 2025[46] - The company repaid approximately $2,000,000 of its Term Loan on October 29, 2025, reducing the outstanding balance to $26,790,000[98] - The company believes that funds generated from operations and existing cash will be sufficient to finance current operations and meet obligations under the Term Loan for the next 12 months[135] Regulatory and Compliance - The company is currently evaluating the impact of adopting ASU 2023-09, which is expected to result in additional disclosures but will not materially affect financial position or results of operations[143] - Management is committed to remediating a previously identified material weakness in internal control over financial reporting related to data accuracy from third-party service organizations[153] - There were no material changes in risk factors from those previously reported in the Annual Report for the year ended December 31, 2024[163]

Financial Performance - Net sales for the three months ended September 30, 2025, were $367.9 million, a decrease of $26.7 million, or 6.8%, compared to the prior year quarter [154]. - Gross profit for the same period was $68.1 million, a decrease of $13.5 million, or 16.6%, with a gross profit margin of 18.5% compared to 20.7% in the prior year [155]. - Operating loss for the three months ended September 30, 2025, was $6.9 million, compared to operating income of $3.1 million in the prior year quarter [160]. - Net loss for the three months ended September 30, 2025, was $20.6 million, or $0.23 per diluted share, compared to a net loss of $19.7 million, or $0.22 per diluted share, in the prior year [167]. - Adjusted EBITDA was $19.7 million for the three months ended September 30, 2025, down from $22.4 million in the prior year [168]. - Organic net sales for the three months ended September 30, 2025, were $341.5 million, a decline of 5.8% compared to the same period in 2024 [200]. - Adjusted EBITDA for the three months ended September 30, 2025, was $19.7 million, compared to $22.4 million in the same period of 2024 [204]. Expenses and Costs - Selling, general and administrative expenses decreased by $5.8 million, or 8.2%, to $65.5 million due to lower employee-related costs [157]. - Productivity and transformation costs increased by $3.2 million, or 63.8%, to $8.2 million, primarily due to costs associated with the Restructuring Program [158]. - Interest and other financing expense increased by $1.8 million, or 12.8%, to $15.5 million, primarily due to higher financing fees [161]. Restructuring Program - The cumulative pretax charges associated with the Restructuring Program are expected to be between $100 million and $110 million [150]. - Annualized pretax savings from the Restructuring Program are expected to be between $130 million and $150 million [151]. Sales by Region - North America net sales for Q3 2025 were $203.9 million, a decrease of $27.2 million or 11.8% from Q3 2024, with organic net sales down 7.4% to $185.0 million [171]. - International net sales for Q3 2025 were $164.0 million, an increase of $0.5 million or 0.3%, while organic net sales decreased by $6.4 million or 3.9% to $156.5 million [175]. Cash Flow and Debt - Cash used in operating activities was $8.5 million for Q3 2025, a decrease of $2.3 million from $10.8 million in the prior year period, primarily due to improved working capital management [192]. - Total debt increased by $11.4 million to $716.2 million as of September 30, 2025, compared to $704.8 million at June 30, 2025 [190]. - Cash and cash equivalents decreased by $6.5 million to $47.9 million as of September 30, 2025, from $54.4 million at June 30, 2025 [190]. - Free cash flow was negative $13.7 million for the three months ended September 30, 2025, an improvement of $2.8 million from negative free cash flow of $16.5 million in the same period of the prior year [195]. Financial Ratios and Covenants - The Company maintained a consolidated secured leverage ratio of 4.81:1.00 as of September 30, 2025, in compliance with all financial covenants [182]. - The Fourth Amendment to the Credit Agreement requires a minimum Consolidated EBITDA of $17.0 million for the quarter ending September 30, 2025 [186]. - The weighted average interest rate on outstanding borrowings under the Credit Agreement was 7.78% as of September 30, 2025, with a commitment fee of 0.25% per annum on unused amounts [188]. Share Repurchase and Goodwill - The company had $173.5 million of remaining authorization under the share repurchase program as of September 30, 2025 [196]. - The company did not repurchase any shares under the repurchase program during the three months ended September 30, 2025 [196]. - As of September 30, 2025, goodwill associated with the U.S. and U.K. reporting units had a carrying value of $312.3 million and $114.0 million, respectively [210]. Market Capitalization - The company expects that its market capitalization should reconcile within a reasonable range to the sum of the fair values of its individual reporting units [211].

Financial Performance - Consolidated revenues for Q3 2025 were $561,741,000, a decrease of 6.3% from $599,614,000 in Q3 2024[130]. - Operating income for Q3 2025 was $55,518,000, down 40.6% from $93,653,000 in Q3 2024[130]. - Adjusted operating income for Q3 2025 was $94,446,000, a decline of 28.2% compared to $131,476,000 in Q3 2024[130]. - Total revenues for the nine months ended September 30, 2025, were $1,716,998,000, down 5.8% from $1,822,009,000 in the same period of 2024[130]. - Total net revenues for Q3 2025 decreased by 6.3% to $561.7 million compared to $599.6 million in Q3 2024, with a 1.8% decline in subscription revenues and a 12.6% drop in advertising revenues[150]. - For the nine months ended September 30, 2025, total revenues decreased by 5.9% to $1.5 billion compared to $1.6 billion for the same period in 2024[193]. - Segment adjusted operating income for the three months ended September 30, 2025, was $112.2 million, a decrease of 25.3% from $150.2 million in 2024[193]. - Operating income for the nine months ended September 30, 2025, was $175,080, down from $233,137 in 2024, representing a decline of 25%[244]. - Net income for the nine months ended September 30, 2025, was $144,867, compared to $222,139 in 2024, indicating a decrease of 34.8%[244]. - Free cash flow for the nine months ended September 30, 2025, was $231,922, down from $293,255 in 2024, a decline of 20.9%[251]. Revenue Sources - The Domestic Operations segment includes five programming networks and various streaming services, contributing significantly to subscription revenues[131]. - Subscription revenues are primarily based on a per-subscriber fee, with variations depending on distributor agreements and subscriber counts[136]. - The International segment generates revenue mainly from subscription fees paid by distributors, with a focus on Europe and Latin America[144]. - Subscription revenues for the Domestic Operations segment increased by 0.1% due to higher streaming revenues, while International segment subscription revenues decreased by 0.9% primarily due to a non-renewal of a distribution agreement in Spain[151]. - Advertising revenues decreased by 17.4% in the Domestic Operations segment, while increasing by 15.3% in the International segment, driven by higher pricing in the U.K. and Ireland[152]. - Content licensing and other revenues fell by 26.7% in the Domestic Operations segment, attributed to lower licensing sales of key shows[153]. Expenses - Content expenses represent the largest expense in both Domestic and International segments, primarily due to amortization of program rights[140][145]. - Total operating expenses for Q3 2025 were $506.2 million, a slight increase of 0.1% compared to $506.0 million in Q3 2024[150]. - Selling, general and administrative expenses increased by 4.6% to $412.3 million for the nine months ended September 30, 2025, compared to $394.1 million in 2024[193]. - Selling, general and administrative expenses increased primarily due to higher corporate overhead costs and marketing costs, with a notable increase in the nine months ended September 30, 2025 compared to 2024[211][212]. - Technical and operating expenses (excluding depreciation and amortization) decreased by 0.3% to $738.5 million for the nine months ended September 30, 2025, compared to $740.5 million in 2024[193]. Financial Position - As of September 30, 2025, cash and cash equivalents totaled $716.8 million, with $146.0 million held by foreign subsidiaries[216]. - The company had $1.9 billion of debt outstanding as of September 30, 2025, with approximately 87% of this debt being fixed rate[253]. - The fair value of the company's fixed rate debt was estimated at $1.72 billion, which is $48.9 million higher than its carrying value of $1.67 billion[252]. - The total net leverage ratio as of September 30, 2025 was approximately 4.33:1.00, below the maximum allowed ratio of 5.75:1.00[227]. - The company has authorized a stock repurchase program of up to $1.5 billion, with $124.9 million remaining for repurchase as of September 30, 2025[231][230]. - Contractual obligations decreased by $44.6 million to $550.7 million as of September 30, 2025, primarily due to payments for program rights[240]. Risks and Future Outlook - The company faces risks from economic conditions, including high inflation and interest rates, which may impact operations and financial position[146]. - Future performance may be affected by market volatility and economic downturns, leading to lower demand for products and services[147]. - The company expects continued linear subscriber declines in the Domestic Operations segment, consistent with trends across the cable ecosystem[151]. Other Financial Activities - The company repurchased $99.1 million principal amount of Senior Notes at a discount of $26.7 million during the second quarter of 2025, recording a gain of $25.8 million[180]. - Interest expense for Q3 2025 decreased by 1.2% to $44.6 million, while interest income decreased by 34.3% to $6.1 million[175][176]. - The company recognized a foreign currency transaction loss of $3.3 million for the three months ended September 30, 2025, and a gain of $13.4 million for the nine months ended September 30, 2025[256]. - Net cash provided by operating activities was $256.4 million, down from $317.5 million in 2024[233]. - Net cash used in financing activities for the nine months ended September 30, 2025 was $317.2 million, primarily related to the tender offer for Senior Notes and principal payments on the Term Loan A Facility[237][238].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ☐ EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-13270 FLOTEK INDUSTRIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0023731 (State of other jurisdiction of ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39228 CLARITEV CORPORATION (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdicti ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) De ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) (S ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) De ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-11689 Fair Isaac Corporation (Exact name of registrant as specified in its charter) Delaware 94-1499887 (State or other ...